However, lack of targeted and endocytic ability of PLD to cancer cells and the passive diffused cytotoxic mechanism of PLD may make it hard to eliminate all resident cancer cells after primary debulking surgery, thereby elevating the relapse frequency of ovarian cancer12 or even inducing severe adverse events that decrease quality of life of ovarian cancer patients during treatment13. This evidence concerns the gene GPLD1 and cancer.